glp-1 news october 1 2025 obesity drug today Right now, Maryland Medicaid does NOT cover the new class of GLP-1 medications for obesity—despite their proven effectiveness. "The reason why we hear so much GLP-1 RA prescription trends: January
Description
Dulaglutide is a long-acting GLP-1 receptor agonist used for type 2 diabetes and weight management
In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits.
Provider-guided care in Oregon, Washington, and California
What does evidence say about GLP-1 agonists and suicidal ideation
Introduction Cinnamon is currently marketed as a remedy for obesity, glucose intolerance, diabetes mellitus and dyslipidaemia
